Jounce Therapeutics, Inc. (JNCE)
After hours:
Chart Events
Performance Outlook
| Previous Close | 3.0600 |
| Open | 3.0700 |
| Bid | 2.8100 x 2200 |
| Ask | 2.8100 x 1100 |
| Day's Range | 2.7600 - 3.1800 |
| 52 Week Range | 2.7600 - 9.8100 |
| Volume | |
| Avg. Volume | 393,095 |
| Market Cap | 144.688M |
| Beta (5Y Monthly) | 1.15 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.9810 |
| Earnings Date | Aug 03, 2022 - Aug 08, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 13.83 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for JNCE
Related Research
- Jounce Therapeutics, Inc.Daily – Vickers Top Buyers & Sellers for 05/28/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.RatingFair ValueEconomic Moatlast yearArgus Research
- GlobeNewswire
Jounce Therapeutics to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass., May 17, 2022 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that Jounce management will participate at the following upcoming investor conferences: H.C. Wainwright Global Investment Conference: Presentation will be available for on-demand viewing starting Tuesday, May 24, 2022 at 7:00 a.m. ET. Cowen’s 3rd Annual Oncology Inn
- Simply Wall St.
Analysts Are More Bearish On Jounce Therapeutics, Inc. (NASDAQ:JNCE) Than They Used To Be
The analysts covering Jounce Therapeutics, Inc. ( NASDAQ:JNCE ) delivered a dose of negativity to shareholders today...
- Simply Wall St.
Jounce Therapeutics (NASDAQ:JNCE) shareholders have endured a 80% loss from investing in the stock five years ago
Some stocks are best avoided. We don't wish catastrophic capital loss on anyone. Imagine if you held Jounce...
